Cargando…

COVID-19 INFECTIONS IN VACCINATED PATIENTS WITH INFLAMMATORY BOWEL DISEASE: OUTCOMES AND RISK FACTORS FOR SEVERE DISEASE

Detalles Bibliográficos
Autores principales:	Spiera, Emily, Ganjian, Danielle, Zhang, Xian, Brenner, Erica, Agrawal, Manasi, Colombel, Jean-Frederic, Kappelman, Michael, Kornbluth, Asher, Ungaro, Ryan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	Uncontrolled Therapeutic Observations in Humans Using Biologic or Non-Biologic Agents
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770920/ http://dx.doi.org/10.1053/j.gastro.2021.12.216

Ejemplares similares

ANTI-SARS-COV-2 VACCINATION AND ANTIBODY RESPONSE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE ON IMMUNE-MODIFYING THERAPY. PROSPECTIVE SINGLE TERTIARY CENTER STUDY ON 602 IBD PATIENTS
por: Cerna, Karin, et al.
Publicado: (2022)

Outcomes of COVID-19 Infections in Vaccinated Patients with Inflammatory Bowel Disease: Data From an International Registry
por: Spiera, Emily, et al.
Publicado: (2022)

Su1493: COVID-19 RELATED THROMBOTIC, CARDIOVASCULAR, AND RENAL COMPLICATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM AN INTERNATIONAL REGISTRY
por: Spiera, Emily, et al.
Publicado: (2022)

Uncontrolled hypertension in patients with type 2 diabetes: What are the correlates?
por: Rabizadeh, Soghra, et al.
Publicado: (2021)

Factors associated with uncontrolled blood pressure in hypertensive Brazilians
por: Araújo, Thayza de Paula, et al.
Publicado: (2022)

Fr496 THE EFFECTS OF COMORBIDITIES ON COVID-19 OUTCOMES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE
por: Parekh, Rajen, et al.
Publicado: (2021)

Presence of Comorbidities Associated with Severe Coronavirus Infection in Patients with Inflammatory Bowel Disease
por: Parekh, Rajen, et al.
Publicado: (2021)

Impact of Medications on COVID-19 Outcomes in Inflammatory Bowel Disease: Analysis of More Than 6000 Patients From an International Registry
por: Ungaro, Ryan C., et al.
Publicado: (2022)

Fr498 NEW GASTROINTESTINAL SYMPTOMS ARE COMMON IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH COVID-19: DATA FROM AN INTERNATIONAL REGISTRY
por: Ungaro, Ryan C., et al.
Publicado: (2021)

Fr509 COVID-19 OUTCOMES AMONG RACIAL AND ETHNIC MINORITY INDIVIDUALS WITH INFLAMMATORY BOWEL DISEASES IN THE UNITED STATES
por: Agrawal, Manasi, et al.
Publicado: (2021)

Fr494 THE IMPACT OF VEDOLIZUMAB THERAPY ON COVID-19 OUTCOMES IN ADULT IBD PATIENTS IN THE SECURE-IBD REGISTRY
por: Agrawal, Manasi, et al.
Publicado: (2021)

COVID-19 mRNA Vaccine Short-Term Safety in Patients With Inflammatory Bowel Disease
por: Spiera, Emily, et al.
Publicado: (2022)

The Impact of Vedolizumab on COVID-19 Outcomes Among Adult IBD Patients in the SECURE-IBD Registry
por: Agrawal, Manasi, et al.
Publicado: (2021)

The inexorable increase of biologic exposure in paediatric inflammatory bowel disease: a Scottish, population‐based, longitudinal study
por: Burgess, Christopher J., et al.
Publicado: (2022)

Characteristics and Outcomes of IBD Patients with COVID-19 on Tofacitinib Therapy in the SECURE-IBD Registry
por: Agrawal, Manasi, et al.
Publicado: (2020)

COVID-19 Outcomes Among Racial and Ethnic Minority Individuals With Inflammatory Bowel Disease in the United States
por: Agrawal, Manasi, et al.
Publicado: (2021)

Benign Evolution of SARS-Cov2 Infections in Children With Inflammatory Bowel Disease: Results From Two International Databases
por: Brenner, Erica J., et al.
Publicado: (2021)

The Multiple Waves of COVID-19 in Patients With Inflammatory Bowel Disease: A Temporal Trend Analysis
por: Kaplan, Gilaad G, et al.
Publicado: (2022)

Fr491 MULTIVARIABLE PREDICTION MODELS FOR HOSPITALIZATION, VENTILATION, AND DEATH FROM COVID-19 IN IBD PATIENTS
por: Sperger, John, et al.
Publicado: (2021)

COVID-19 and Inflammatory Bowel Disease: Lessons Learned, Practical Recommendations, and Unanswered Questions
por: Ungaro, Ryan C., et al.
Publicado: (2021)

Sa502 THE FIRST AND SECOND WAVE OF COVID-19 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: A TEMPORAL TREND ANALYSIS
por: Kaplan, Gilaad, et al.
Publicado: (2021)

Inflammatory Bowel Disease Clinical Activity is Associated with COVID-19 Severity Especially in Younger Patients
por: Ricciuto, Amanda, et al.
Publicado: (2021)

Physician Practice Patterns in Holding Inflammatory Bowel Disease Medications due to COVID-19, in the SECURE-IBD Registry
por: Agrawal, Manasi, et al.
Publicado: (2020)

Development and validation of multivariable prediction models for adverse COVID-19 outcomes in patients with IBD
por: Sperger, John, et al.
Publicado: (2021)

Development and validation of multivariable prediction models for adverse COVID-19 outcomes in IBD patients
por: Sperger, John, et al.
Publicado: (2021)

Risks of Development of COVID-19 Among Patients With Inflammatory Bowel Disease: A Comparative Assessment of Risk Factors for Incident Infection
por: Long, Millie D, et al.
Publicado: (2022)

Abnormal prion protein, infectivity and neurofilament light-chain in blood of macaques with experimental variant Creutzfeldt-Jakob disease
por: Yakovleva, Oksana, et al.
Publicado: (2022)

Working Together to Meet the Needs of Patients With Inflammatory Bowel Diseases
por: Brenner, Erica J., et al.
Publicado: (2021)

A Patient-Prioritized Agenda for Information Needs During the COVID-19 Pandemic: A Qualitative Study of Patients With Inflammatory Bowel Disease
por: Long, Millie D, et al.
Publicado: (2021)

Trends in Surgical Recurrence Among Pediatric Crohn’s Disease Patients Using Administrative Claims Data
por: Egberg, Matthew D, et al.
Publicado: (2023)

IBD in the COVID-19 era: the value of international collaboration
por: Brenner, Erica J, et al.
Publicado: (2020)

Reply
por: Brenner, Erica J., et al.
Publicado: (2021)

Reappraisal of Coronavirus Disease 2019 Risk for Patients With Inflammatory Bowel Disease: Withdrawal of the British Society of Gastroenterology Inflammatory Bowel Disease Risk Grid
por: Ungaro, Ryan C., et al.
Publicado: (2023)

Reversal of ApoE4-induced recycling block as a novel prevention approach for Alzheimer’s disease
por: Xian, Xunde, et al.
Publicado: (2018)

Measuring Human Water Needs
por: Wutich, Amber, et al.
Publicado: (2019)

Antidepressant medication use in Inflammatory Bowel Disease: a nationally representative population‐based study
por: Jayasooriya, Nishani, et al.
Publicado: (2022)

Disease and Treatment Patterns Among Patients With Pouch-related Conditions in a Cohort of Large Tertiary Care Inflammatory Bowel Disease Centers in the United States
por: Barnes, Edward L, et al.
Publicado: (2020)

Coordinating a new approach to basic research into Parkinson’s disease
por: Schekman, Randy, et al.
Publicado: (2019)

Characterization of small fiber pathology in a mouse model of Fabry disease
por: Hofmann, Lukas, et al.
Publicado: (2018)

Characteristics of Fecal Microbiota Transplantation Use in Inflammatory Bowel Disease Cohort
por: Bauer, Christina M, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lvp7i33v25ubvmi4lkvhjlvrko